DSM-Firmenich AG
AEX:DSFIR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
85.51
123.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
DSM-Firmenich AG
Other Items
DSM-Firmenich AG
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Other Items
-€42m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sika AG
F:SIKA
|
Other Items
-CHf3.2B
|
CAGR 3-Years
-199%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-23%
|
|
|
C
|
Clariant AG
SIX:CLN
|
Other Items
-CHf735m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Givaudan SA
SIX:GIVN
|
Other Items
CHf155m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Other Items
CHf81.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Other Items
CHf10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
DSM-Firmenich AG
Glance View
DSM-Firmenich AG is a global leader in the nutrition, health, and beauty sectors, born from the merger of Dutch multinational DSM and Swiss flavor and fragrance company Firmenich. This innovative company specializes in creating sustainable solutions, leveraging science and technology to enhance the quality of life across a diverse range of industries, including food, beverages, personal care, and pharmaceuticals. With a robust portfolio of products aimed at enriching human and environmental health, DSM-Firmenich aims to meet the growing consumer demand for healthier, more sustainable options. Their commitment to sustainability positions them favorably within the markets they serve, as consumers increasingly seek brands that prioritize their health and the planet. For investors, DSM-Firmenich stands out not just for its impressive offerings but also for its strategic vision that emphasizes long-term growth and resilience. The company's strong financial track record, combined with its focus on innovation and operational efficiency, underpins its potential to capitalize on emerging trends within the wellness and sustainability industries. As global populations expand and consumer preferences shift towards health-conscious choices, DSM-Firmenich is well-placed to leverage its expertise and comprehensive understanding of the market. By investing in this forward-thinking enterprise, investors can participate in a company that is not only poised for financial success but also dedicated to making a positive impact on society and the environment.
See Also
What is DSM-Firmenich AG's Other Items?
Other Items
-42m
EUR
Based on the financial report for Dec 31, 2023, DSM-Firmenich AG's Other Items amounts to -42m EUR.
You don't have any saved screeners yet
